Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Expression deregulation of matrix metalloproteinases and vasoconstriction related genes in Pakistani females with abnormal uterine bleeding

View through CrossRef
Abstract Background Abnormal uterine bleeding (AUB) is irregular menstrual bleeding which has great impact on female health and life style. Various genetic factors are involved in etiology and pathology of AUB. Present study was designed to explore the association of PTGFR, MMP9, MMP2, TGFB3 and VEGFB with AUB. Methods Blood samples of 212 females with AUB were collected along with age-matched healthy control. Expression variation of targeted genes was evaluated using qPCR. Present study cohort was divided into different groups based on demographic parameters and all targeted genes were correlated with study demographics. Results Expression of targeted genes was significantly (P < 0.001) downregulated in females with AUB compared to control. Reduced (P < 0.01) expression of targeted genes was observed in all age groups (21–30, 31–40, 41–50 year) of AUB patients compared to respective control. Expression of VEGFB increased (P < 0.05) in AUB females with > 9 days bleeding compared to AUB patient had < 9 days bleeding. AUB women with miscarriage history showed upregulation in MMP2, TGFB3 (P < 0.05), and downregulation in MMP9 and VEGFB (P < 0.05) expression compared to AUB group with no miscarriage history. Expression of MMP2 increased (P < 0.05) in AUB females with > 60 kg body weigh compared to AUB patient with < 60 kg weight. Conclusion Present study open a new window for diagnosis of AUB at early stages and suggested a possible involvement of PTGFR, MMP9, MMP2, TGFB3 and VEGFB as candidate biomarkers in AUB.
Title: Expression deregulation of matrix metalloproteinases and vasoconstriction related genes in Pakistani females with abnormal uterine bleeding
Description:
Abstract Background Abnormal uterine bleeding (AUB) is irregular menstrual bleeding which has great impact on female health and life style.
Various genetic factors are involved in etiology and pathology of AUB.
Present study was designed to explore the association of PTGFR, MMP9, MMP2, TGFB3 and VEGFB with AUB.
Methods Blood samples of 212 females with AUB were collected along with age-matched healthy control.
Expression variation of targeted genes was evaluated using qPCR.
Present study cohort was divided into different groups based on demographic parameters and all targeted genes were correlated with study demographics.
Results Expression of targeted genes was significantly (P < 0.
001) downregulated in females with AUB compared to control.
Reduced (P < 0.
01) expression of targeted genes was observed in all age groups (21–30, 31–40, 41–50 year) of AUB patients compared to respective control.
Expression of VEGFB increased (P < 0.
05) in AUB females with > 9 days bleeding compared to AUB patient had < 9 days bleeding.
AUB women with miscarriage history showed upregulation in MMP2, TGFB3 (P < 0.
05), and downregulation in MMP9 and VEGFB (P < 0.
05) expression compared to AUB group with no miscarriage history.
Expression of MMP2 increased (P < 0.
05) in AUB females with > 60 kg body weigh compared to AUB patient with < 60 kg weight.
Conclusion Present study open a new window for diagnosis of AUB at early stages and suggested a possible involvement of PTGFR, MMP9, MMP2, TGFB3 and VEGFB as candidate biomarkers in AUB.

Related Results

Abnormal uterine bleeding and associated factors among reproductive age women in Jimma town, Oromia Region, Southwest Ethiopia
Abnormal uterine bleeding and associated factors among reproductive age women in Jimma town, Oromia Region, Southwest Ethiopia
Introduction: Abnormal uterine bleeding is any bleeding that deviates from normal menstruations. It differs in terms of frequency of bleeding, duration, and the pattern of bleeding...
Bleeding Risk Factors in Thrombocytopenic Patients with Hematologic Malignancies
Bleeding Risk Factors in Thrombocytopenic Patients with Hematologic Malignancies
Introduction Despite prophylactic platelet transfusions, World Health Organization (WHO) grade ≥ 2 bleeding occurs in 50 to 70% of patients with hematologic malignan...
Blood Transfusion Trends in Women With Abnormal Uterine Bleeding [14D]
Blood Transfusion Trends in Women With Abnormal Uterine Bleeding [14D]
INTRODUCTION: Blood transfusion continues to pose serious risks to recipients. The role of blood transfusion in management of women presenting with abnormal uterine ble...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract Introduction Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...

Back to Top